Erratum to: Low IgA and IgM Is Associated with a Higher Prevalence of Bronchiectasis in Primary Antibody Deficiency (Journal of Clinical Immunology, (2017), 37, 4, (329-331), 10.1007/s10875-017-0381-y);Low IgA and IgM Is Associated with a Higher Prevalence of Bronchiectasis in Primary Antibody Deficiency

Journal of Clinical Immunology

Volumn 37, Issue 4, 2017, Pages 329-331

  Hodkinson, John P ^a   Bangs, Catherine ^b   Wartenberg Demand, Andrea ^c   Bauhofer, Artur ^c   Langohr, Patrick ^c   Buckland, Matthew S ^d   Guzman, David ^e   Yong, Patrick F K ^f   Kiani Alikhan, Sorena ^f  

^a Biotest UK Ltd   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c BIOTEST AG   (Germany)

^d BARTS HEALTH NHS TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f Royal Surrey and Frimley Park NHS Foundation Trusts   (United Kingdom)

Author keywords

Bronchiectasis; Common Variable Immunodeficiency; Infective Complication; Prophylactic Antibiotic; Thymoma

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBIOTIC PROPHYLAXIS; BLOOD; BRONCHIECTASIS; DYSGAMMAGLOBULINEMIA; HUMAN; PREVALENCE; UNITED KINGDOM;

ANTIBIOTIC PROPHYLAXIS; BRONCHIECTASIS; DYSGAMMAGLOBULINEMIA; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREVALENCE; UNITED KINGDOM;

EID: 85015161487     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-017-0392-8     Document Type: Erratum

References (8)

1. Gathmann B, Mahlaoui N, Ceredih GL, Oksenhendler E, Warnatz K, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116–26. DOI: 10.1016/j.jaci.2013.12.1077
2. Kiani-Alikhan S, Yong PF, Grosse-Kreul D, Elston C, Ibrahim MA. Immunoglobulin replacement therapy: is there a role for IgA and IgM? J Allergy Clin Immunol. 2012;130(2):553–4. author reply 4 DOI: 10.1016/j.jaci.2012.04.032
3. Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol. 2011;31(3):315–22. DOI: 10.1007/s10875-011-9511-0
4. Cerutti A, Chen K, Chorny A. Immunoglobulin responses at the mucosal interface. Annu Rev Immunol. 2011;29:273–93. DOI: 10.1146/annurev-immunol-031210-101317
5. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125(6):1354–60. e4 DOI: 10.1016/j.jaci.2010.02.040
6. Verma N, Grimbacher B, Hurst JR. Lung disease in primary antibody deficiency. Lancet Respir Med. 2015;3(8):651–60. DOI: 10.1016/S2213-2600(15)00202-7
7. A Milford Ward, J Sheldon, A Rowbottom and GD Wild. Protein Reference Unit Handbook in Clinical Immunochemistry 2007 (9th Edition).
8. Cavaliere FM, Milito C, Martini H, Schlesier M, Drager R, Schutz K, et al. Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency. J Clin Immunol. 2013;33(4):838–46. DOI: 10.1007/s10875-012-9856-z